Mereo BioPharma Group/$MREO
About Mereo BioPharma Group
Ticker
Industry
Employees
MREO Metrics
$474M
-
-$0.31
0.91
-
Price and volume
Market cap
$474M
Beta
0.91
52-week high
$5.02
52-week low
$2.53
Average daily volume
1M
Financial strength
Current ratio
6.104
Quick ratio
5.834
Long term debt to equity
0.543
Total debt to equity
9.211
Interest coverage (TTM)
-28.24%
Management effectiveness
Return on equity (TTM)
-62.11%
Valuation
Price to revenue (TTM)
441.176
Price to book
6.52
Price to tangible book (TTM)
6.59
Price to free cash flow (TTM)
-14.275
Growth
Revenue change (TTM)
-88.89%
Earnings per share change (TTM)
26.92%
3-year revenue growth (CAGR)
-72.65%
3-year earnings per share growth (CAGR)
-9.64%
What the Analysts think about MREO
Analyst Ratings
MREO Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
MREO Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
MREO News
FAQs
What’s the current market cap for Mereo BioPharma Group stock?
What is the P/E ratio for Mereo BioPharma Group stock?
Does Mereo BioPharma Group stock pay dividends?
No, Mereo BioPharma Group (MREO) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Mereo BioPharma Group dividend payment date?
Mereo BioPharma Group (MREO) stock does not pay dividends to its shareholders.
What is the beta indicator for Mereo BioPharma Group?
Mereo BioPharma Group (MREO) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.